Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

10 Jul 2020 | 09:01 AM

438.40
6.65 (1.54%)

  • Underperforms Index

    -2.87%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 31.66%

  • More Volatile

    4.04%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.48%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

573

572.70

168

168.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -5.47% since past 3 Months

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -8.04% since past 3 Months

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -12.59% since past 1 Year

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -10.43% since past 1 Year

Loading...